by Elana Gotkine Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract disease (LRTD) among adults aged 60 years or older, according to a study published online Dec. 13 in JAMA Network Open. Sara Y. Tartof, Ph.D., M.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues estimated RSVpreF vaccine effectiveness in older adults in...
Tag: <span>RSV</span>
Post
CDC study shows nirsevimab effective in reducing RSV hospitalizations among young children
by Justin Jackson , Medical Xpress Transmission electron micrograph of RSV. Credit: CDC/ Dr. Erskine Palmer / Public Domain Research led by the CDC and conducted at seven academic pediatric medical centers in the United States finds nirsevimab (sold as Beyfortus) highly effective in reducing respiratory syncytial virus (RSV) related hospitalization in children under 5...
Post
RSV found to infect nerve cells & may cause inflammatory nerve damage
By Paul McClure Researchers have found that RSV, very common in children, can also infect and damage nerve tissue Depositphotos Thought only to infect the respiratory tract, new research has proved for the first time that the respiratory syncytial virus (RSV), very common in young children, can also penetrate nerve cells directly, triggering excessive inflammation and...
Post
RSV shown to infect nerve cells, cause inflammation and damage
by Tulane University Transmission electron micrograph of RSV. Credit: CDC/ Dr. Erskine Palmer / Public DomainRespiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane University study. RSV can cause mild symptoms such as coughing, sneezing and...
Post
US approves maternal vaccine to prevent RSV in infants
Credit: CC0 Public Domain The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies. The Pfizer shot, which was already approved for use in older adults, has now been greenlighted for use as a single injection from...
Post
Researchers discover antibody that neutralizes both RSV and human metapneumovirus
by Anthony Czelusniak, Vanderbilt University James Crowe, Jr., MD, left, and Naveenchandra Suryadevara, PhD, have discovered a monoclonal antibody with therapeutic potential that neutralizes both RSV and hMPV. Credit: Vanderbilt University Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). The findings,...
Post
FDA approves first RSV vaccine, a long-sought scientific achievement
By Helen Branswell May 3, 2023 Reprints KENZO TRIBOUILLARD/AFP VIA GETTY IMAGES The Food and Drug Administration on Wednesday licensed the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making. The product, GSK’s Arexvy, was approved for adults ages 60 and older. GSK beat a crowded field of...
Post
Study finds RSV may evade vaccines via rapid mutation
by Bill Snyder, Vanderbilt University Seasonality of RSV cases in children hospitalized with lower respiratory tract infection in Buenos Aires between 2014 and 2017. (A) A cumulative bar graph of the number of positive cases of respiratory viruses detected per month per year. Dotted lines represent the minimum and maximum temperatures recorded per month per...
Post
How can I tell if my child has RSV?
by Laura Hegwer, Rush University Medical Center Credit: Unsplash/CC0 Public Domain With all the news about RSV surging in infants and toddlers, you may be wondering what to do if your kid gets a stuffy nose or fever this fall. You’re in good company—even parents who work as pediatric health care providers struggle sometimes. “It’s...
Post
Q&A: What to know about RSV
by Hilary Brown, University of Kentucky Credit: Pixabay/CC0 Public Domain Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. Pediatricians across the country are seeing a significant increase in RSV...
- 1
- 2